Zinpentraxin alfa

泽穿透素-α

Report date: 2025/07/11 20:01:15

Base Information

Drug NameZinpentraxin alfa
Drug Alias NameSerum amyloid PSAPPENTRAXIN-2Recombinant Human Serum Amyloid Precombinant human pentraxin-2 (Roche) +[10] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionLow affinity immunoglobulin gamma Fc region receptor III agonists
TargetsLow affinity immunoglobulin gamma Fc region receptor III
Therapy Area/IndicationsPrimary MyelofibrosisThrombocythemia, EssentialGlaucoma +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[35] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesPromedior Inc
China Registration ClassN/A

Develop Information

Active CompaniesF. Hoffmann-La Roche Ltd
Inactive CompaniesRoche (China) Holding Ltd
Active IndicationsCrohn DiseaseInflammatory Bowel Diseases
Inactive IndicationsPrimary MyelofibrosisThrombocythemia, EssentialGlaucoma +[6] 

Other Information

ATC CodeN/A
Related LinksDrugBank